Medartis on Track for Growth Targets After First Half

Medartis reported 1H23 orthopedic sales of CHF 103.3 million ($112.6 million), +16.8% compared to the first half of 2022.

The company achieved strong performances in EMEA and the U.S. While all of Medartis' European markets contributed, Germany accounted for a third of all regional growth during the half. Slightly offsetting this strength,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us